NASDAQ:CBPO
Delisted
China Biologic Products Stock News
$119.99
+0 (+0%)
At Close: May 27, 2022
China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction
08:45pm, Wednesday, 20'th May 2020
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today declared that Xinjiang Deyua
China Biologic Products Q1 EPS $1.560 Beats $1.380 Estimate, Sales $162.600M Up From $129.784M YoY
08:32pm, Wednesday, 20'th May 2020China Biologic Reports Financial Results for the First Quarter of 2020
08:30pm, Wednesday, 20'th May 2020
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited fina
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
12:00am, Wednesday, 20'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 19)
ADC Therapeutics SA (NYSE:...
The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows
12:00am, Sunday, 17'th May 2020
Biotech stocks had another up week, with the American Society of Gene & Stem Cell Therapy virtual conference presentations and the ASCO abstracts made available online ...
Oxford Asset Management Buys iShares MSCI Emerging Index Fund, Ra Pharmaceuticals Inc, Forty ...
12:00am, Friday, 15'th May 2020Sand Grove Capital Management LLP Buys ForeScout Technologies Inc, Caesars Entertainment Corp, ...
12:00am, Thursday, 14'th May 2020China Biologic Products to Report First Quarter 2020 Financial Results
12:30pm, Tuesday, 12'th May 2020
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company
BFAM Partners (Cayman) Ltd Buys Alibaba Group Holding, NIO Inc, China Biologic Products ...
12:00am, Tuesday, 12'th May 2020Maso Capital Partners Ltd Buys Allergan PLC, China Biologic Products Holdings Inc, Cypress ...
12:00am, Monday, 11'th May 2020Myriad Asset Management Ltd. Buys NVIDIA Corp, Splunk Inc, HDFC Bank, Sells ZTO Express ...
12:00am, Tuesday, 05'th May 2020China Biologic Products Earns Relative Strength Rating Upgrade; Hits Key Threshold
12:00am, Monday, 04'th May 2020Growth investment is set to accelerate Polyplus' expansion in partnership with Warburg Pincus and ArchiMed
12:00pm, Wednesday, 29'th Apr 2020
Polyplus-transfection® SA ("Polyplus"), a developer of innovative and cost-effective technology used in gene and cell therapy, closed on a major investment from Warburg Pincus, a leading global priva
Brokerages Anticipate China Biologic Products Holdings Inc (NASDAQ:CBPO) Will Post Earnings of $1.38 Per Share
09:34am, Thursday, 23'rd Apr 2020
Brokerages expect China Biologic Products Holdings Inc (NASDAQ:CBPO) to report earnings of $1.38 per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Chin
